How do I hire a fractional head of revenue for a medical device company in 2027?

This vs. the common alternatives

A fractional head of revenue is one of three paths founders consider when the revenue function needs leadership but a full-time executive salary isn't yet justified. The other two are a fractional VP of Sales and an interim CRO, and conflating them leads to the wrong hire.

A fractional CRO owns the whole revenue function — sales, marketing, customer success, channel partnerships, and revenue operations — typically for 10-20 days per month across multiple concurrent clients. This is the right fit when a medical device company has no established sales team and needs someone to simultaneously define the ideal customer profile, build a hospital system sales process, stand up a CRM, and start closing early deals. A fractional VP of Sales, by contrast, manages only the direct sales team and pipeline execution. If you already have three or more reps and a functioning marketing motion, a fractional VP of Sales can plug the gap in day-to-day pipeline management without the broader mandate — but you'll lose the cross-functional coordination a CRO provides between clinical marketing, channel distributors, and revenue operations.

An interim CRO is a different structure entirely: full-time, usually 40+ hours a week, engaged for a defined period (commonly 6 months) to replace a departed executive or bridge a search. Interim engagements cost close to full-time compensation on a pro-rated basis and are best suited to companies that already have revenue scale (typically above $5M ARR) and simply need continuity while they recruit a permanent CRO. For a pre-revenue or early-revenue medical device company — under roughly $1M in bookings — the fractional CRO model is almost always the better fit because it is capital-efficient and lets the founder test fit before committing to a six-figure salary and full equity grant.

The mistake to avoid is hiring a fractional executive whose only relevant experience is selling software to medical device companies, rather than selling medical devices themselves. That's an adjacent skill, not the same skill — the buyer psychology, procurement calendar, and regulatory messaging constraints are specific enough that a fast learner from SaaS will typically take 6-12 months to become effective, by which point a domain expert would already have delivered results.

How to choose between them

The decision hinges on three variables: your current revenue stage, whether a sales team already exists, and how much cross-functional coordination the business needs right now.

Start by mapping your stage honestly. Pre-revenue companies need strategic guidance and go-to-market design more than they need a closer — this is a 10 day/month engagement focused on ICP definition, messaging, and channel strategy. Early-revenue companies (roughly under $1M) need someone who splits time between strategy and hands-on execution — building the pipeline, running early sales calls, and setting up the CRM — which typically pushes the engagement to 15-20 days/month. Companies scaling from $1M-$10M need the most hands-on version: pipeline management, channel partner recruitment, hiring plans for SDRs and account executives, and formal board reporting.

Next, check whether cross-functional ownership is the actual gap. If your problem is narrowly "we have leads but nobody is closing them," a fractional VP of Sales may be sufficient and cheaper. If your problem is "we don't have a repeatable process for getting from a hospital's initial interest to a signed GPO contract," you need the broader mandate of a fractional CRO, because that problem touches marketing (how leads are qualified), sales (how the pitch is delivered), regulatory (what claims can be made), and operations (how the CRM tracks a multi-stakeholder deal).

Finally, weigh urgency against risk tolerance. A fractional engagement ramps in 2-4 weeks because there's no relocation, no notice period, and no full negotiation cycle — compare that to 8-12 weeks for a full-time CRO once you account for a notice period and onboarding. The fractional structure is also lower risk: a poor fit can be exited with 30 days' notice and no severance, versus the cultural disruption and severance cost of a failed full-time executive hire.

Costs, timelines, and expected impact

Fractional CRO compensation for a medical device company breaks into three components: cash retainer, equity, and milestone bonuses.

The cash retainer is the largest piece and scales with days committed per month, company stage, and geographic expectations. A pre-revenue company engaging someone for 10 days a month at the low end of the market should expect a materially lower monthly retainer than a Series A company asking for 20 days a month plus on-site hospital visits and board reporting — the difference between the two commonly runs 2-3x. Compare this to a full-time CRO, who typically commands a $250,000-$400,000 base salary plus benefits and 5-10% equity, with a 12-24 month minimum commitment. The fractional path costs a fraction of that cash burden while preserving optionality.

Equity for a fractional CRO usually lands between 0% and 5% of fully diluted shares, vesting over 2-3 years with a 6-month cliff — far below the 5-10% a full-time CRO would command, reflecting the part-time, multi-client nature of the engagement. Some fractional executives will accept a higher equity stake in place of cash for very early-stage companies, but this is uncommon; most fractional CROs need predictable cash flow across their client portfolio and won't discount heavily.

Milestone bonuses are increasingly standard and should be tied to outcomes the company actually needs — first six figures of new bookings, or the first signed hospital system contract — never to vanity metrics like meetings booked. This keeps the fractional CRO's incentives aligned with revenue outcomes rather than activity.

On timelines, expect a 2-4 week ramp before the fractional CRO is fully engaged, versus 8-12 weeks for a full-time hire once notice periods and relocation are factored in. Engagement length typically runs 6-12 months, structured as an initial 3-month pilot with a 30-day out clause, extending if the fit is strong. Most engagements naturally end — meaning the company graduates to a full-time CRO — once the company crosses roughly $3M-$5M in ARR and the revenue function is complex enough to justify a full-time salary and a larger equity grant.

Medical device sales cycles complicate the impact timeline. Because the buying cycle runs 9-18 months from first contact to purchase — spanning surgeon evaluation, hospital administrator cost review, GPO committee approval, and reimbursement coding confirmation — a fractional CRO's first 90 days should be judged on pipeline-building activity (qualified opportunities created, a documented sales playbook, territory plans) rather than closed revenue, which may not materialize until well into the engagement's second half.

Implementation and handoff details

Once you've decided to hire, the process runs through five concrete steps.

First, write a fractional CRO brief. This should specify your company's stage, target hospital or IDN segment, current sales cycle length, existing team composition, and the specific mix of strategy, hands-on execution, and hiring support you need. A vague brief attracts vague candidates.

Second, source candidates through networks that specialize in fractional revenue leadership placement rather than general executive search — specialized RevOps and CRO communities tend to have pre-vetted candidates with documented track records, which shortens the diligence cycle considerably compared to a cold LinkedIn search.

Third, interview specifically for regulatory and procurement fluency. Ask direct questions: how have they navigated hospital GPO contracts with groups like Vizient, Premier, or HealthTrust? What is their experience with sales cycles tied to 510(k) clearance or CE marking under MDR? Generic SaaS-background candidates will struggle to answer these with specificity, and that gap predicts how they'll perform once engaged.

Fourth, use a 90-day plan as a structured evaluation tool. Ask finalist candidates to submit a one-page outline of what they would do in their first 90 days. Strong submissions include a revenue audit of current pipeline and tech stack, a 6-month forecast with stated assumptions, a hiring plan for key roles like SDRs or a channel manager, and a specific set of weekly leading indicators. Weak submissions default to vague language like "build pipeline" with no measurable detail — that's a signal to move on.

Fifth, structure the engagement itself around a technology and process sequence that avoids over-engineering. In the first 60 days, the fractional CRO should be able to operate with just a CRM (commonly Salesforce or HubSpot, configured with custom fields for regulatory status, hospital system hierarchy, and GPO contract stage) and a spreadsheet for forecasting — resist the urge to layer in sales engagement platforms or revenue intelligence tools before the core process is proven. Define 3-5 KPIs directly in the contract — pipeline value created, qualified opportunities, sales playbook delivered — and pay monthly so you can exit cleanly by month two if targets are missed.

For handoff continuity, require that all process documentation — CRM configuration notes, the sales playbook, channel partner contacts, and the current pipeline state — live in a shared company-owned folder from day one, not in the fractional executive's personal files. This protects the company if the engagement ends unexpectedly; most fractional CROs will provide 30 days' transition notice, and having documentation already centralized means a successor can be productive within days rather than weeks.

Related questions

How much does a fractional CRO cost for an early-stage company?

Cash retainer scales with days committed (10-20/month) and stage, plus 0-5% vesting equity and optional milestone bonuses tied to closed revenue or signed hospital contracts — far below a full-time CRO's $250K-$400K salary plus benefits.

What's the difference between a fractional CRO and an interim CRO?

A fractional CRO works part-time across multiple clients; an interim CRO works full-time for a defined bridge period, usually replacing a departed executive at companies with more revenue scale.

Can a fractional CRO help raise a funding round?

Yes — a strong fractional CRO builds the revenue model, pipeline forecast, and sales narrative investors expect, and can join board meetings and investor calls, which is a common reason founders engage one pre-Series A.

Do fractional CROs need to visit hospitals in person?

Most engagements are remote-first but include at least one on-site visit per quarter for clinical team meetings, trade shows, or hospital system relationship building — medical device sales still depend on in-person demos.

When should a company transition from fractional to full-time revenue leadership?

Most companies convert once they cross roughly $3M-$5M in ARR, when the revenue function's complexity justifies a full-time salary and larger equity commitment.

FAQ

What is the typical engagement length for a fractional head of revenue in medical device? Most run 6-12 months, structured as an initial 3-month pilot with a 30-day out clause, extending if results and fit are strong. Engagements typically end once the company scales past $3M-$5M ARR.

How is a fractional CRO different from a fractional VP of Sales? A fractional CRO owns the entire revenue function — sales, marketing, customer success, channel, and revenue operations. A fractional VP of Sales manages only direct sales and pipeline, which is sufficient only if a marketing function and multiple reps already exist.

What should I look for in a candidate's background? Direct experience selling medical devices or capital equipment into hospitals, IDNs, or surgery centers, ideally with GPO exposure (Vizient, Premier, HealthTrust). Avoid candidates whose only relevant experience is selling software to medical device companies.

How do I structure a pilot to limit risk? Use a 3-month pilot with a 30-day out clause, 3-5 KPIs defined in the contract (pipeline value, qualified opportunities, playbook delivered), and monthly payment so you can exit cleanly if targets are missed by month two.

What technology should the fractional CRO set up first? A CRM (Salesforce or HubSpot) configured for regulatory status and hospital hierarchy, plus a spreadsheet for forecasting — for the first 60 days, avoid adding sales engagement or revenue intelligence platforms until the core process is proven.

What happens if the fractional CRO leaves mid-engagement? Documentation stored in a shared company folder (playbook, CRM notes, partner contacts) protects continuity. Most fractional executives give 30 days' transition notice, and specialized networks can typically supply a replacement within 2-4 weeks.

Sources

• Pavilion — Community for revenue leaders
• RevOps Co-op — Revenue operations community
• Harvard Business Review — Sales leadership articles
• First Round Review — Startup revenue playbooks
• SaaStr — Go-to-market advice for founders
• FDA — Device clearance and approval process
• Vizient — Group purchasing organization

Related on PULSE

• How do I structure a fractional CRO compensation package with milestone bonuses?
• What KPIs should I track in a fractional revenue leadership pilot?
• When should a startup convert a fractional CRO into a full-time hire?
• How do hospital GPO contracts affect medical device sales cycles?
• What's the difference between a fractional VP of Sales and a full-time VP of Sales?